HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul K Whelton Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

7/2010ALLHAT: still providing correct answers after 7 years.
3/2009Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study.
1/2008Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
4/2007Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
4/2005Prevalence of the metabolic syndrome and overweight among adults in China.
10/2004Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
2/2004The metabolic syndrome and chronic kidney disease in U.S. adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul K Whelton Research Topics

Disease

91Hypertension (High Blood Pressure)
11/2023 - 04/2002
46Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 03/2002
28Myocardial Infarction
01/2019 - 04/2005
17Stroke (Strokes)
01/2023 - 05/2002
14Diabetes Mellitus
12/2022 - 05/2006
11Heart Failure
01/2019 - 07/2002
9Chronic Renal Insufficiency
01/2021 - 02/2003
9Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 03/2002
7Weight Loss (Weight Reduction)
11/2022 - 02/2002
7Coronary Disease (Coronary Heart Disease)
11/2014 - 09/2003
7Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2010 - 02/2004
6Obesity
01/2022 - 11/2007
6Overweight
01/2022 - 02/2002
6Hypotension (Low Blood Pressure)
01/2021 - 02/2004
5Type 2 Diabetes Mellitus (MODY)
12/2022 - 06/2005
5Acute Kidney Injury (Acute Renal Failure)
01/2021 - 12/2003
5Prehypertension
01/2018 - 07/2005
4Syncope (Fainting)
01/2021 - 11/2015
4Insulin Resistance
03/2009 - 02/2003
3Isolated Systolic Hypertension
01/2021 - 01/2018
3Body Weight (Weight, Body)
03/2016 - 09/2014
3Peripheral Arterial Disease
11/2014 - 02/2006
3Abdominal Obesity
03/2009 - 02/2004
2Inflammation (Inflammations)
09/2015 - 10/2004
2Renal Insufficiency (Renal Failure)
06/2007 - 03/2002
2Dyslipidemias (Dyslipidemia)
04/2004 - 12/2003
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2023
1Bradycardia
01/2021
1COVID-19
01/2021
1Prediabetic State (Prediabetes)
11/2019
1Masked Hypertension
01/2019
1White Coat Hypertension
01/2019
1Pediatric Obesity
01/2018
1Essential Hypertension
01/2018
1Atherosclerosis
01/2018
1Headache (Headaches)
01/2016
1Tremor (Tremors)
01/2016

Drug/Important Bio-Agent (IBA)

57Antihypertensive Agents (Antihypertensives)IBA
11/2023 - 02/2002
29SodiumIBA
01/2023 - 02/2002
25LipidsIBA
04/2017 - 04/2005
23Chlorthalidone (Chlortalidone)FDA LinkGeneric
11/2022 - 04/2005
18DiureticsIBA
01/2024 - 04/2005
18Amlodipine (Norvasc)FDA LinkGeneric
11/2022 - 04/2005
17Lisinopril (Prinivil)FDA LinkGeneric
01/2018 - 04/2005
13Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2022 - 04/2005
13Glucose (Dextrose)FDA LinkGeneric
11/2019 - 02/2003
11Dietary SodiumIBA
06/2023 - 07/2002
11Calcium Channel Blockers (Blockers, Calcium Channel)IBA
11/2022 - 04/2005
9ThiazidesIBA
11/2022 - 04/2005
9PotassiumIBA
11/2022 - 10/2002
6SaltsIBA
06/2023 - 04/2002
6CreatinineIBA
01/2022 - 03/2002
6Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2018 - 01/2018
6Triglycerides (Triacylglycerol)IBA
10/2016 - 02/2004
5Amiloride (Midamor)FDA LinkGeneric
04/2021 - 04/2016
4CholesterolIBA
12/2022 - 07/2004
4ElectrolytesIBA
01/2021 - 11/2015
4HDL CholesterolIBA
03/2009 - 02/2004
4Fibrinogen (Factor I)FDA Link
12/2004 - 06/2003
4C-Reactive ProteinIBA
12/2004 - 06/2003
3Hydrochlorothiazide (Esidrix)FDA LinkGeneric
11/2022 - 03/2009
3Losartan (Cozaar)FDA LinkGeneric
04/2021 - 04/2016
3Dietary PotassiumIBA
12/2018 - 02/2014
2amsonic acid (DAS)IBA
01/2023 - 01/2022
2Indicators and Reagents (Reagents)IBA
01/2018 - 01/2016
2Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2017 - 07/2010
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2016 - 02/2003
2Blood Glucose (Blood Sugar)IBA
12/2016 - 11/2006
2LDL CholesterolIBA
10/2016 - 05/2006
2CarbohydratesIBA
03/2016 - 08/2011
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
12/2010 - 09/2008
2Doxazosin (Cardura)FDA LinkGeneric
05/2009 - 01/2008
2Dietary FiberFDA Link
03/2005 - 09/2003
2Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2004 - 01/2004
2Insulin (Novolin)FDA Link
10/2004 - 02/2003
2HomocysteineIBA
01/2004 - 06/2003
2Vitamin A (Retinol)FDA LinkGeneric
12/2002 - 03/2002
2VitaminsIBA
12/2002 - 03/2002
2AntioxidantsIBA
12/2002 - 03/2002
1EnalaprilFDA LinkGeneric
11/2022
1Angiotensin Receptor AntagonistsIBA
11/2022
1candesartanIBA
11/2022
1AldosteroneIBA
01/2021
1AdiponectinIBA
01/2018
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
09/2015
1Triclosan (pHisoHex)FDA Link
06/2015
1Milk Proteins (Milk Protein)IBA
08/2011
1CalciumIBA
07/2010
1ORALIT (ORS)IBA
06/2009
1benazepril (Briem)FDA LinkGeneric
03/2009

Therapy/Procedure

21Therapeutics
11/2022 - 04/2005
6Drug Therapy (Chemotherapy)
11/2022 - 02/2002
3Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
03/2016 - 09/2014
3Fat-Restricted Diet (Diet, Fat Restricted)
03/2016 - 09/2014
1Dietary Approaches To Stop Hypertension
01/2022
1Complementary Therapies (Alternative Medicine)
11/2018
1Glycemic Control
01/2018
1Diet Therapy (Therapy, Diet)
01/2018
1Lasers (Laser)
01/2016